Mamisan Lidocaine Ointment Containers Are Recalled by Plantimex

On December 18, 2025, Plantimex, the manufacturer, recalled Mamisan lidocaine ointment containers because of a risk of serious injury or death from child poisoning, resulting from a violation of the mandatory standard for child-resistant packaging. The Poison Prevention Packaging Act requires that lidocaine be in child-resistant packaging to prevent the possibility of a young child swallowing it. If your child was harmed by lidocaine ointment, call the experienced Chicago-based product liability lawyers of Moll Law Group about whether you have grounds to sue. Billions have been recovered in litigation with which we’ve been involved.

Call Moll Law Group About Your Lidocaine Claim

Around 50,330 units of Mamisan Pain Relieving Topical Ointment jars with the UPC code 860006498115 were recalled. The 3.52-ounce plastic jar that holds the ointment is orange. It has a white continuous thread lid with the Mamisan trademark printed on top of the lid and label. There is also a wraparound label that has instructions and facts printed on it.

If you purchased one of these jars, you’re advised to secure the recalled jars out of children’s sight and reach. You can get a free child-resistant replacement lid from Plantimex. The product can continue to be used once the replacement lid has been put into place.

No injuries have been reported so far. However, you should be aware that lidocaine is meant to be used topically or sometimes as a local anesthetic via injection. Additionally, there is a prescription formula that may be swallowed in prescribed doses as advised by a doctor to treat throat and mouth pain. However, ingesting lidocaine can result in serious harms; it can build up in the blood and thereby impact organs. This, in turn, can result in problems in the central nervous system, such as dizziness, tinnitus, confusion, light-headedness, blurred vision, slowed breathing, seizures, and coma. Problems with the heart’s electrical system may also develop, causing slower heart rate, low blood pressure, irregular heartbeat, or sometimes a heart attack. Ingestion of lidocaine can even result in a blood disorder known as methemoglobinemia.

Small children are at a greater risk of serious injuries from consuming lidocaine—it should never be given to young children, according to FDA warnings, because there’s always a risk that the child will consume too much.

While a free replacement lid is helpful, it does nothing to address serious harms that occur as a result of lidocaine ingestion. If your child was injured by consuming lidocaine that was in one of the recalled jars, you may have grounds to sue. When we’re able to establish a manufacturer’s liability, we may be able to recover economic and noneconomic damages. The nature of your child’s injuries will determine what damages are available. However, generally, we can recover compensation for medical bills such as ER visits, hospital stays, doctor’s bills, and the like. Additionally, we may be able to recover damages that represent noneconomic losses such as for pain and suffering and mental anguish and emotional distress.

If your child was injured because he or she ingested lidocaine due to a non-child-resistant container of Mamisan ointment, call the seasoned Chicago-based product liability lawyers of Moll Law Group to figure out whether you have a viable claim for damages. We dedicate ourselves to fighting for injured consumers around the country. Complete our online form or call us at 312.462.1700.